{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T18:18:55Z","timestamp":1765995535097,"version":"build-2065373602"},"reference-count":81,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Sciences"],"abstract":"<jats:p>Background\/Objectives: Carotid artery disease is a condition affecting 3% of the general population which significantly contributes to the development of cerebrovascular events. Fibroblast Growth Factor-23 (FGF-23) is a hormone that has been linked to atherosclerosis and increased cardiovascular risk, including stroke and myocardial infarction. This review explores the association of FGF-23 with carotid artery disease progression in an endarterectomy clinical context. Methods: Based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), a search was performed relying on MEDLINE, Scopus and Web of Science, identifying publications focused on the correlation between serum FGF-23 and carotid artery disease. Assessment of study quality was made using National Heart, Lung and Blood Institute Study Quality Assessment Tool (NHLBI). Results: Three observational studies, comprising 1039 participants, were included. There was considerable heterogeneity among the populations from the different studies. Elevated FGF-23 levels were consistently associated with unstable plaque features, including intraplaque neovascularization, as identified through Superb Microvascular Imaging (SMI). Plasma levels of inflammatory mediators, such as Interleukin-6 (Il-6), Monocyte Chemoattractant Protein-1 (MCP-1), and Osteoprotegerin (OPG), positively correlated with carotid artery disease, but their link to unstable plaques is conflicting. None of the studies investigated clinical complications following carotid endarterectomy. Conclusions: FGF-23 is a potential biomarker for plaque vulnerability in carotid disease. Despite promising findings, limitations such as small sample sizes and lack of longitudinal data suggest the need for larger and more diverse studies to improve risk stratification and inform personalized treatment strategies for carotid atherosclerosis.<\/jats:p>","DOI":"10.3390\/medsci13010027","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T06:59:59Z","timestamp":1741589999000},"page":"27","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["FGF-23 as a Biomarker for Carotid Plaque Vulnerability: A Systematic Review"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1332-4748","authenticated-orcid":false,"given":"Joana","family":"Oliveira-Sousa","sequence":"first","affiliation":[{"name":"RISE-Health, Department of Biomedicine, Unit of Anatomy, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal"}]},{"given":"Mariana","family":"Frag\u00e3o-Marques","sequence":"additional","affiliation":[{"name":"RISE-Health, Department of Biomedicine, Unit of Anatomy, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal"}]},{"given":"Lu\u00eds","family":"Duarte-Gamas","sequence":"additional","affiliation":[{"name":"Department of Angiology and Vascular Surgery, Local Health Unit T\u00e2mega e Sousa, 4560-136 Penafiel, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6623-7420","authenticated-orcid":false,"given":"Hugo","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"RISE-Health, Department of Biomedicine, Unit of Anatomy, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal"},{"name":"Faculty of Medicine, University of Coimbra, 3004-528 Coimbra, Portugal"},{"name":"Community Palliative Care Team Gaia\u2013Local Health Unit Gaia and Espinho, 4434-502 Vila Nova de Gaia, Portugal"},{"name":"Coimbra Institute for Clinical and Biomedical Research, 3000-548 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2656-8935","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Rocha-Neves","sequence":"additional","affiliation":[{"name":"RISE-Health, Department of Biomedicine, Unit of Anatomy, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.semvascsurg.2021.02.013","article-title":"Epidemiology of atherosclerotic carotid artery disease","volume":"34","author":"Dossabhoy","year":"2021","journal-title":"Semin. Vasc. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1016\/j.lpm.2016.10.003","article-title":"Epidemiology of stroke in Europe and trends for the 21st century","volume":"45","author":"Bejot","year":"2016","journal-title":"Presse M\u00e9d."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejvs.2017.06.021","article-title":"Editor\u2019s Choice\u2014Management of Atherosclerotic Carotid and Vertebral Artery Disease: 2017 Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS)","volume":"55","author":"Naylor","year":"2018","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/STROKEAHA.108.535070","article-title":"Postpublication external review of the Japanese guidelines for the management of stroke 2004","volume":"40","author":"Shinohara","year":"2009","journal-title":"Stroke"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejvs.2022.04.011","article-title":"Editor\u2019s Choice\u2014European Society for Vascular Surgery (ESVS) 2023 Clinical Practice Guidelines on the Management of Atherosclerotic Carotid and Vertebral Artery Disease","volume":"65","author":"Naylor","year":"2023","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/01.STR.0000173153.51295.ee","article-title":"Carotid atherosclerotic plaque characteristics are associated with microembolization during carotid endarterectomy and procedural outcome","volume":"36","author":"Verhoeven","year":"2005","journal-title":"Stroke"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Niculescu, R., Russu, E., Arbanasi, E.M., Kaller, R., Arbanasi, E.M., Melinte, R.M., Cosarca, C.M., Cocuz, I.G., Sabau, A.H., and Tinca, A.C. (2022). Carotid Plaque Features and Inflammatory Biomarkers as Predictors of Restenosis and Mortality Following Carotid Endarterectomy. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph192113934"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Miceli, G., Basso, M.G., Pintus, C., Pennacchio, A.R., Cocciola, E., Cuffaro, M., Profita, M., Rizzo, G., and Tuttolomondo, A. (2024). Molecular Pathways of Vulnerable Carotid Plaques at Risk of Ischemic Stroke: A Narrative Review. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202402.1730.v1"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1093\/ndt\/gfq309","article-title":"FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment","volume":"25","author":"Seiler","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.4103\/ijn.IJN_506_20","article-title":"Fibroblast Growth Factor-23 in Pre-Dialysis Chronic Kidney Disease Patients and its Correlation with Carotid Artery Calcification","volume":"32","author":"Kumar","year":"2022","journal-title":"Indian J. Nephrol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.7754\/Clin.Lab.2015.141236","article-title":"Fibroblast Growth Factor-23 and Carotid Artery Intima Media Thickness in Chronic Kidney Disease","volume":"61","author":"Yilmaz","year":"2015","journal-title":"Clin. Lab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3988\/jcn.2020.16.1.29","article-title":"Plasma Fibroblast Growth Factor 23 Concentration Is Associated with Intracranial Cerebral Atherosclerosis in Acute Ischemic Stroke Patients","volume":"16","author":"Chang","year":"2020","journal-title":"J. Clin. Neurol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.111.053405","article-title":"Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23","volume":"125","author":"Lim","year":"2012","journal-title":"Circulation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/cvr\/cvv187","article-title":"Membrane-bound Klotho is not expressed endogenously in healthy or uraemic human vascular tissue","volume":"108","author":"Mencke","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s10157-016-1357-6","article-title":"The FGF23 and Klotho system beyond mineral metabolism","volume":"21","author":"Kuro","year":"2017","journal-title":"Clin. Exp. Nephrol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1373\/clinchem.2013.206649","article-title":"Pathophysiological implications of fibroblast growth factor-23 and Klotho and their potential role as clinical biomarkers","volume":"60","year":"2014","journal-title":"Clin. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Vogt, I., Haffner, D., and Leifheit-Nestler, M. (2019). FGF23 and Phosphate-Cardiovascular Toxins in CKD. Toxins, 11.","DOI":"10.3390\/toxins11110647"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41569-023-00903-0","article-title":"FGF23 and klotho at the intersection of kidney and cardiovascular disease","volume":"21","author":"Edmonston","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1681\/ASN.2017121334","article-title":"Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis","volume":"29","author":"Marthi","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejim.2019.12.008","article-title":"Fibroblast growth factor 23 predicts carotid atherosclerosis in individuals without kidney disease. The CORDIOPREV study","volume":"74","author":"Canalejo","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1161\/ATVBAHA.115.305945","article-title":"Fibroblast Growth Factor 23 Is Associated With Carotid Plaque Presence and Area: The Northern Manhattan Study","volume":"35","author":"Shah","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12933-015-0301-5","article-title":"Increased FGF23 serum level is associated with unstable carotid plaque in type 2 diabetic subjects with internal carotid stenosis","volume":"14","author":"Biscetti","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11739-014-1183-3","article-title":"FGF-23 levels in patients with critical carotid artery stenosis","volume":"10","author":"Proietta","year":"2015","journal-title":"Intern. Emerg. Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Zamani, M., Skagen, K., Lindberg, B., Bjerkeli, V., Aukrust, P., Halvorsen, B., and Skjelland, M. (2024). Relationship between fibroblast growth factor in plasma and carotid plaque neovascularization: A pilot study. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1385377"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12933-024-02205-2","article-title":"Relationships of serum FGF23 and alpha-klotho with atherosclerosis in patients with type 2 diabetes mellitus","volume":"23","author":"Bi","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_27","unstructured":"National Heart, L., and Institute, B. (2022, September 18). Study Quality Assessment Tools, Available online: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"ref_29","first-page":"676","article-title":"Carotid artery atheroma: Comparison of preoperative B-mode ultrasound appearance with carotid endarterectomy specimen pathology","volume":"29","author":"Graham","year":"1988","journal-title":"J. Cardiovasc. Surg."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Chua, W., Cardoso, V.R., Guasch, E., Sinner, M.F., Al-Taie, C., Brady, P., Casadei, B., Crijns, H., Dudink, E., and Hatem, S.N. (2023). An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditions. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-42331-7"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2215\/CJN.05080422","article-title":"Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: A Mendelian Randomization Study","volume":"18","author":"Donovan","year":"2023","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2215\/CJN.09570912","article-title":"Serum FGF23 and risk of cardiovascular events in relation to mineral metabolism and cardiovascular pathology","volume":"8","author":"Arnlov","year":"2013","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.numecd.2016.11.009","article-title":"Contribution of fibroblast growth factor 23 to Framingham risk score for identifying subclinical atherosclerosis in Chinese men","volume":"27","author":"Hu","year":"2017","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","article-title":"The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: The Heart and Soul Study","volume":"152","author":"Parker","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00467-013-2575-8","article-title":"High serum phosphorus and FGF 23 levels are associated with progression of coronary calcifications","volume":"29","author":"Srivaths","year":"2014","journal-title":"Pediatr. Nephrol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Nakayama, M., Kaizu, Y., Nagata, M., Ura, Y., Ikeda, H., Shimamoto, S., and Kuma, K. (2013). Fibroblast growth factor 23 is associated with carotid artery calcification in chronic kidney disease patients not undergoing dialysis: A cross-sectional study. BMC Nephrol., 14.","DOI":"10.1186\/1471-2369-14-22"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e000936","DOI":"10.1161\/JAHA.114.000936","article-title":"Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: The Atherosclerosis Risk in Communities study","volume":"3","author":"Lutsey","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1093\/ndt\/gfp205","article-title":"Relationship between circulating FGF23 and total body atherosclerosis in the community","volume":"24","author":"Mirza","year":"2009","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Xiao, Y., Peng, C., Huang, W., Zhang, J., Xia, M., Zhang, Y., and Ling, W. (2013). Circulating fibroblast growth factor 23 is associated with angiographic severity and extent of coronary artery disease. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0072545"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"E426","DOI":"10.1152\/ajpendo.00264.2014","article-title":"FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability","volume":"307","author":"Silswal","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/ki.2010.194","article-title":"FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease","volume":"78","author":"Yilmaz","year":"2010","journal-title":"Kidney Int."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2215\/CJN.13281211","article-title":"Fibroblast growth factor 23 and Inflammation in CKD","volume":"7","author":"Isakova","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.2010.313","article-title":"Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease","volume":"78","author":"Hasegawa","year":"2010","journal-title":"Kidney Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1053\/j.jrn.2010.07.002","article-title":"Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: Complex interactions","volume":"21","author":"Isakova","year":"2011","journal-title":"J. Ren. Nutr."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0014-5793(89)80476-4","article-title":"Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes","volume":"242","author":"Castell","year":"1989","journal-title":"FEBS Lett."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/ajcn\/80.5.1222","article-title":"Truncal fat mass as a contributor to inflammation in end-stage renal disease","volume":"80","author":"Axelsson","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1097\/01.ASN.0000141966.69934.21","article-title":"The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity","volume":"15","author":"Wisse","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.2967\/jnumed.107.038661","article-title":"Role of inflammation in atherosclerosis","volume":"48","author":"Spagnoli","year":"2007","journal-title":"J. Nucl. Med."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Hanks, L.J., Casazza, K., Judd, S.E., Jenny, N.S., and Gutierrez, O.M. (2015). Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122885"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/eci.12588","article-title":"Intact FGF23 and alpha-Klotho during acute inflammation\/sepsis in CKD patients","volume":"46","author":"Dounousi","year":"2016","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2169\/internalmedicine.55.5507","article-title":"Serum Fibroblast Growth Factor 23 (FGF23) in Patients with Rheumatoid Arthritis","volume":"55","author":"Sato","year":"2016","journal-title":"Intern. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cyto.2016.12.022","article-title":"Serum levels of fibroblast growth factor 23 are elevated in patients with active Lupus nephritis","volume":"91","author":"Resende","year":"2017","journal-title":"Cytokine"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/ki.2015.290","article-title":"Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production","volume":"89","author":"David","year":"2016","journal-title":"Kidney Int."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00774-014-0598-2","article-title":"Interleukin-1-induced acute bone resorption facilitates the secretion of fibroblast growth factor 23 into the circulation","volume":"33","author":"Yamazaki","year":"2015","journal-title":"J. Bone Miner. Metab."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41387-018-0037-x","article-title":"A high-fat diet stimulates fibroblast growth factor 23 formation in mice through TNFalpha upregulation","volume":"8","author":"Glosse","year":"2018","journal-title":"Nutr. Diabetes"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s00223-016-0116-8","article-title":"Systemic Inflammation Affects Human Osteocyte-Specific Protein and Cytokine Expression","volume":"98","author":"Pathak","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.mce.2014.10.007","article-title":"Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli","volume":"399","author":"Ito","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/1873-3468.12040","article-title":"Counter-regulatory paracrine actions of FGF-23 and 1,25(OH)2 D in macrophages","volume":"590","author":"Han","year":"2016","journal-title":"FEBS Lett."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.kint.2018.02.026","article-title":"Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease","volume":"94","author":"Hassan","year":"2018","journal-title":"Kidney Int."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.7150\/thno.74785","article-title":"Therapeutic angiogenesis-based strategy for peripheral artery disease","volume":"12","author":"Han","year":"2022","journal-title":"Theranostics"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1161\/CIRCRESAHA.108.181115","article-title":"Vascular endothelial growth factor-A specifies formation of native collaterals and regulates collateral growth in ischemia","volume":"103","author":"Clayton","year":"2008","journal-title":"Circ. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992","journal-title":"Nature"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s40610-019-0110-9","article-title":"Regulation of Fibroblast Growth Factor 23 by Iron, EPO, and HIF","volume":"5","author":"Wheeler","year":"2019","journal-title":"Curr. Mol. Biol. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MNH.0000000000000232","article-title":"Inflammation regulates fibroblast growth factor 23 production","volume":"25","author":"Francis","year":"2016","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"16011","DOI":"10.1038\/boneres.2016.11","article-title":"The hypoxia-inducible factor-1alpha activates ectopic production of fibroblast growth factor 23 in tumor-induced osteomalacia","volume":"4","author":"Zhang","year":"2016","journal-title":"Bone Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nm0603-653","article-title":"Angiogenesis in health and disease","volume":"9","author":"Carmeliet","year":"2003","journal-title":"Nat. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1034\/j.1600-0463.2002.100501.x","article-title":"Mast cells and angiogenesis","volume":"110","author":"Norrby","year":"2002","journal-title":"APMIS"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1161\/ATVBAHA.109.185165","article-title":"Mechanisms of vessel branching: Filopodia on endothelial tip cells lead the way","volume":"29","author":"Segura","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5551\/jat.3004","article-title":"Chronic CRP-exposure inhibits VEGF-induced endothelial cell migration","volume":"17","author":"Schneeweis","year":"2010","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13287-016-0377-1","article-title":"C-reactive protein can upregulate VEGF expression to promote ADSC-induced angiogenesis by activating HIF-1alpha via CD64\/PI3k\/Akt and MAPK\/ERK signaling pathways","volume":"7","author":"Chen","year":"2016","journal-title":"Stem Cell Res. Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1161\/01.STR.30.9.1751","article-title":"The North American Symptomatic Carotid Endarterectomy Trial: Surgical results in 1415 patients","volume":"30","author":"Ferguson","year":"1999","journal-title":"Stroke"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.atherosclerosis.2011.01.002","article-title":"Embolic complications after carotid artery stenting or carotid endarterectomy are associated with tissue characteristics of carotid plaques evaluated by magnetic resonance imaging","volume":"215","author":"Yamada","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jstrokecerebrovasdis.2012.07.018","article-title":"Selection of carotid artery stenting or endarterectomy based on magnetic resonance plaque imaging reduced periprocedural adverse events","volume":"22","author":"Yoshimura","year":"2013","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"26S","DOI":"10.1016\/j.jvs.2021.04.074","article-title":"The Society for Vascular Surgery implementation document for management of extracranial cerebrovascular disease","volume":"75","author":"AbuRahma","year":"2022","journal-title":"J. Vasc. Surg."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association\/American Stroke Association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"I\u2013XLVII","DOI":"10.1177\/23969873211012121","article-title":"European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis","volume":"6","author":"Bonati","year":"2021","journal-title":"Eur. Stroke J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.21037\/atm-20-7197","article-title":"New insight into biology, molecular diagnostics and treatment options of unstable carotid atherosclerotic plaque: A narrative review","volume":"9","author":"Migdalski","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jvs.2018.02.046","article-title":"Best medical treatment alone may not be adequate for all patients with asymptomatic carotid artery stenosis","volume":"68","author":"Paraskevas","year":"2018","journal-title":"J. Vasc. Surg."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1161\/CIRCULATIONAHA.109.887497","article-title":"Composition of carotid atherosclerotic plaque is associated with cardiovascular outcome: A prognostic study","volume":"121","author":"Hellings","year":"2010","journal-title":"Circulation"}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/13\/1\/27\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:49:55Z","timestamp":1760028595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/13\/1\/27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["medsci13010027"],"URL":"https:\/\/doi.org\/10.3390\/medsci13010027","relation":{},"ISSN":["2076-3271"],"issn-type":[{"type":"electronic","value":"2076-3271"}],"subject":[],"published":{"date-parts":[[2025,3,10]]}}}